Known as chimeric antigen receptor (CAR) T-cell therapy, the treatment involves harvesting a patient'cells and genetically modifying them to target and attack specific types of cancers, including lymphomas, leukemias and multiple myeloma. For many people, the treatment has been life-changing — however, as the first CAR T-cell therapy was only , scientists are still learning about the treatment's benefits and risks.

A chemical compound essential to all living things has been synthesized in a lab in conditions that could have occurred on early Earth, suggesting it played a role at the outset of life, finds a new study led by University College London researchers. ...

Tsambali limagwiritsa ntchito makeke kuti akuthandizeni kuyenda, kusanthula momwe mumagwiritsira ntchito ntchito zathu, kusonkhanitsa zidziwitso zakusintha kwamalonda ndikupereka zomwe zili kuchokera kwa anthu ena. Pogwiritsa ntchito tsamba lathu, mumavomereza kuti mwawerenga ndikumvetsetsa Mfundo Zazinsinsi ndi Migwirizano yathu.